Ralox – 50 BOTTLES AT 30 PERCENT OFF

Ralox is a high-purity research compound available exclusively through Revo Peptide for qualified laboratory and scientific research applications. Supplied at ≥98% purity in liquid form at a concentration of 50 mg/mL, this product is manufactured under strict quality control standards to support consistent, reproducible in vitro research outcomes. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Revo Peptide is proud to offer Ralox as part of its expanding catalog of premium research compounds. This bulk 50-bottle configuration delivers exceptional value for research institutions, laboratories, and procurement teams seeking reliable supply continuity. The 30% bulk discount reflects our commitment to making high-quality research materials accessible without compromising analytical integrity or traceability. Each bottle is individually lot-coded and produced to meet the rigorous standards demanded by modern scientific research environments.

Peptide Structure & Amino Acid Sequence

Ralox (CAS 841205-47-8) is characterized by the molecular formula C₁₉H₄F₃N₃O₃. It is a synthetic small-molecule compound rather than a traditional peptide chain, meaning it does not carry a conventional amino acid sequence. Its trifluoromethyl-substituted aromatic scaffold and nitrogen-containing heterocyclic core contribute to its distinct physicochemical profile, making it a subject of considerable interest in biochemical and pharmacological research settings.

Chemical & Physical Characteristics

• CAS Number: 841205-47-8
• Molecular Formula: C₁₉H₄F₃N₃O₃
• Concentration: 50 mg/mL
• Appearance: Clear liquid
• Physical State: Liquid
• Molecular Weight: Referenced under CAS 841205-47-8

The clear liquid presentation of Ralox at 50 mg/mL allows for straightforward volumetric measurement and integration into standard laboratory workflows. Its liquid format eliminates the reconstitution step required for lyophilized compounds, reducing preparation time and minimizing handling variables during experimental setup.

Purity & Analytical Verification (HPLC & MS)

Every batch of Ralox supplied by Revo Peptide undergoes rigorous analytical verification to confirm a minimum purity of ≥98%. High-Performance Liquid Chromatography (HPLC) is employed to assess compound identity and purity profiles, while Mass Spectrometry (MS) confirms molecular weight integrity and the absence of significant impurity peaks. Lot number 132456 has been verified against these analytical benchmarks, and documentation is available to support laboratory record-keeping and research compliance requirements.

Quality Control & Lyophilization Integrity

As a liquid compound, Ralox does not undergo lyophilization. Instead, quality control focuses on solution stability, concentration accuracy, and container integrity. Each unit is sealed under controlled conditions to prevent contamination, evaporation, or degradation prior to delivery. Revo Peptide’s internal QC protocols ensure that every bottle dispatched meets the stated concentration and purity specifications, providing researchers with confidence in the consistency of their starting material across all experimental replicates.

Safety, Handling & Laboratory Precautions

Ralox is intended solely for use by trained laboratory professionals operating within appropriately equipped research facilities. Standard laboratory safety precautions should be observed at all times, including the use of appropriate personal protective equipment (PPE) such as gloves, eye protection, and lab coats. Avoid inhalation of vapors and contact with skin or mucous membranes. Refer to your institution’s chemical safety guidelines and applicable local regulations when handling, storing, or disposing of this compound. This product is strictly not for human or veterinary use.

Reconstitution, Packaging & Storage

Ralox is supplied ready-to-use in liquid format at 50 mg/mL — no reconstitution is required. Each bottle should be stored according to your facility’s standard protocols for liquid research compounds. Protect from direct light and extreme temperature fluctuations. Ensure bottles are tightly sealed after each use to maintain concentration integrity. The 50-bottle bulk configuration is packaged to withstand standard laboratory logistics and is suitable for both immediate use and medium-term inventory management.

Intended Research Use & Market Positioning

Ralox is positioned within Revo Peptide’s catalog as a high-value research compound for use in biochemical assays, receptor binding studies, and related in vitro experimental models. It is not approved for any clinical, therapeutic, or diagnostic application. Researchers investigating molecular targets relevant to the compound’s structural class will find this product a reliable and cost-effective addition to their reagent inventory, particularly when sourced in bulk at the 30% discounted rate.

Ordering, Availability & Fulfillment

Revo Peptide offers this 50-bottle Ralox bulk package with a 30% discount, representing significant savings for high-volume research procurement. Orders are processed promptly, with fulfillment managed through our established logistics network to ensure timely and secure delivery. Buy online today through Revo Peptide’s secure checkout. For larger institutional requirements or custom volume orders, contact our team to discuss wholesale pricing options that may yield savings of up to 50%. Order now to lock in the best price and secure your research supply.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Ralox (CAS 841205-47-8) is sold exclusively as a laboratory research compound by Revo Peptide. It is the sole responsibility of the purchasing institution or individual researcher to ensure that acquisition, storage, handling, and use of this compound comply with all applicable local, national, and international laws and regulations. Revo Peptide makes no representations regarding the suitability of this compound for any application beyond its intended in vitro research use.